COVID-19

Dataset Records for COVID-19

Displaying 101 - 150 of 1564

Time period covered (start date)

Year

Time period covered (start date)

Year

Kenya Nairobi Performance Monitoring and Action Agile Youth Respondent Driven Sampling Survey Round 3 2021

PMA Agile/PMA Gender Kenya (Nairobi) Youth Respondent-Driven Sampling Survey Round 3 Dataset, Version 1.0

Survey: Individual - Interview - Longitudinal

GHDx Entry last modified on: Oct 7, 2024

[Seroprevalence to SARS-CoV-2 among the population of the Belgorod Region amid the COVID-19 epidemic]

Scientific literature

GHDx Entry last modified on: Mar 14, 2022

Australia Household Impacts of Covid-19 Survey March 2021

Survey: Household - Individual - Interview - Longitudinal - Nationally representative

GHDx Entry last modified on: Mar 2, 2023

Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after the start of the COVID-19 pandemic. Preprint

Scientific literature

GHDx Entry last modified on: Sep 13, 2022

Denmark Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021

ZA7780: Eurobarometer 94.3 (2021)

Survey: Cross-sectional - Individual - Interview

GHDx Entry last modified on: Nov 12, 2024

Spain Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021

ZA7780: Eurobarometer 94.3 (2021)

Survey: Cross-sectional - Individual - Interview

GHDx Entry last modified on: Nov 13, 2024

Finland Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021

ZA7780: Eurobarometer 94.3 (2021)

Survey: Cross-sectional - Individual - Interview

GHDx Entry last modified on: Nov 12, 2024

France Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021

ZA7780: Eurobarometer 94.3 (2021)

Survey: Cross-sectional - Individual - Interview

GHDx Entry last modified on: Nov 12, 2024

Greece Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021

ZA7780: Eurobarometer 94.3 (2021)

Survey: Cross-sectional - Individual - Interview

GHDx Entry last modified on: Nov 19, 2024

Italy Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021

ZA7780: Eurobarometer 94.3 (2021)

Survey: Cross-sectional - Individual - Interview

GHDx Entry last modified on: Nov 12, 2024

Netherlands Dutch National Bank Household Survey 2021

DNB Household Survey

Survey: Cross-sectional - Household - Individual

GHDx Entry last modified on: Nov 20, 2024

Lithuania Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021

ZA7780: Eurobarometer 94.3 (2021)

Survey: Cross-sectional - Individual - Interview

GHDx Entry last modified on: Nov 19, 2024

Portugal National Serological Survey COVID-19 (2nd phase) 2021

Inquérito Serológico Nacional COVID-19 (2.ª fase) (INS COVID-19)

Survey: Individual

GHDx Entry last modified on: Nov 3, 2022

Jharkhand: 45% of population in 10 districts positive before 2nd wave: Sero survey

Survey: Epi surveillance

GHDx Entry last modified on: Aug 2, 2022

Luxembourg Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021

ZA7780: Eurobarometer 94.3 (2021)

Survey: Cross-sectional - Individual - Interview

GHDx Entry last modified on: Nov 7, 2024

North Macedonia Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021

ZA7780: Eurobarometer 94.3 (2021)

Survey: Cross-sectional - Individual - Interview

GHDx Entry last modified on: Nov 7, 2024

Brazil - Sergipe Evolution of the Prevalence of SARS-CoV-2 Infection 2021, Third Phase

Evolução da Prevalência de Infecção por SARS-CoV-2 em Sergipe. Terceira Fase: 18 de fevereiro a 30 de março de 2021.

Survey: Epi surveillance

GHDx Entry last modified on: Jul 13, 2022

Malta Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021

ZA7780: Eurobarometer 94.3 (2021)

Survey: Cross-sectional - Individual - Interview

GHDx Entry last modified on: Nov 12, 2024

Montenegro Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021

ZA7780: Eurobarometer 94.3 (2021)

Survey: Cross-sectional - Individual - Interview

GHDx Entry last modified on: Nov 7, 2024

Poland Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021

ZA7780: Eurobarometer 94.3 (2021)

Survey: Cross-sectional - Individual - Interview

GHDx Entry last modified on: Nov 7, 2024

Bosnia and Herzegovina Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021

ZA7780: Eurobarometer 94.3 (2021)

Survey: Cross-sectional - Individual - Interview

GHDx Entry last modified on: Nov 7, 2024

Romania Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021

ZA7780: Eurobarometer 94.3 (2021)

Survey: Cross-sectional - Individual - Interview

GHDx Entry last modified on: Nov 18, 2024

Switzerland Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021

ZA7780: Eurobarometer 94.3 (2021)

Survey: Cross-sectional - Individual - Interview

GHDx Entry last modified on: Nov 12, 2024

Serbia Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021

ZA7780: Eurobarometer 94.3 (2021)

Survey: Cross-sectional - Individual - Interview

GHDx Entry last modified on: Nov 19, 2024

Netherlands - Coronavirus antibodies in an average of 18.6% of the donors

Antistoffen coronavirus bij gemiddeld 18,6% van de donors

Epi surveillance

GHDx Entry last modified on: May 12, 2022

Cyprus Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021

ZA7780: Eurobarometer 94.3 (2021)

Survey: Cross-sectional - Individual - Interview

GHDx Entry last modified on: Nov 7, 2024

Slovakia Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021

ZA7780: Eurobarometer 94.3 (2021)

Survey: Cross-sectional - Individual - Interview

GHDx Entry last modified on: Nov 19, 2024

Germany Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021

ZA7780: Eurobarometer 94.3 (2021)

Survey: Cross-sectional - Individual - Interview

GHDx Entry last modified on: Nov 19, 2024

Slovenia Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021

ZA7780: Eurobarometer 94.3 (2021)

Survey: Cross-sectional - Individual - Interview

GHDx Entry last modified on: Nov 19, 2024

Brazil - Tocantins COVID-19 Epidemiological Bulletin 2021

Boletim Epidemiológico Notificação para COVID-19 2021

Epi surveillance

GHDx Entry last modified on: May 12, 2022

Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021. Preprint

Scientific literature

GHDx Entry last modified on: May 12, 2022

COVID-19 antibody seroprevalence in Duhok, Kurdistan Region, Iraq: A population-based study. Preprint

Scientific literature

GHDx Entry last modified on: Mar 14, 2022

Post-COVID-19 Syndrome: Nine Months after SARS-CoV-2 Infection in a Cohort of 354 Patients: Data from the First Wave of COVID-19 in Nord Franche-Comté Hospital, France

Scientific literature

GHDx Entry last modified on: Nov 11, 2024

SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy

Scientific literature

GHDx Entry last modified on: Jan 31, 2024

Identification of spectrum of persistent post-COVID-19 symptoms and their duration in Central India: A pilot study

Scientific literature

GHDx Entry last modified on: Mar 22, 2024

Incidence and Characterization of Post-COVID-19 Symptoms in Hospitalized COVID-19 Survivors to Recognize Syndemic Connotations in India: Single-Center Prospective Observational Cohort Study

Scientific literature

GHDx Entry last modified on: Mar 22, 2024

Association Between Guillain-Barré Syndrome and COVID-19 Infection and Vaccination: A Population-Based Nested Case-Control Study

Scientific literature

GHDx Entry last modified on: Oct 23, 2024

SARS-CoV-2 seroprevalence in Chattogram, Bangladesh before a National Lockdown, March-April 2021. Preprint

Scientific literature

GHDx Entry last modified on: Mar 14, 2022

Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study

Scientific literature

GHDx Entry last modified on: Apr 10, 2023

Herd immunity to SARS-CoV-2 among the population of the Republic of Belarus amid the COVID-19 pandemic

Scientific literature

GHDx Entry last modified on: Apr 10, 2023

United States Behavioral Risk Factor Surveillance System 2021

Survey: Cross-sectional - Household - Individual - Interview - Nationally representative - Subnationally representative

GHDx Entry last modified on: Oct 23, 2024

Evaluation of bacterial coinfections and susceptible antibiotic profiles in hospitalized COVID-19 patients in Koya district, Iraq

Scientific literature

GHDx Entry last modified on: Sep 17, 2024

United States COVID-19 Data Tracker: Variant Proportions

CDC COVID Data Tracker

Epi surveillance

GHDx Entry last modified on: Aug 11, 2021

Seroprevalence of anti-SARS-CoV-2 antibodies six months into the vaccination campaign in Geneva, Switzerland. Preprint

Scientific literature

GHDx Entry last modified on: Mar 14, 2022

SARS-CoV-2 Herd Immunity of the Kyrgyz Population in 2021. Preprint

Scientific literature

GHDx Entry last modified on: Apr 8, 2022

Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study

Scientific literature

GHDx Entry last modified on: Apr 10, 2023

Characteristics and predictors of Long COVID among diagnosed cases of COVID-19

Scientific literature

GHDx Entry last modified on: Mar 22, 2024

Post COVID-19 condition after delta infection and omicron reinfection in children and adolescents

Scientific literature

GHDx Entry last modified on: Mar 22, 2024

Twelve Months and Counting: Following Clinical Outcomes in Critical COVID-19 Survivors

Scientific literature

GHDx Entry last modified on: Mar 22, 2024

Analysis of Post-COVID-19 Guillain-Barré Syndrome over a Period of One Year in the University Hospital of Split (Croatia)

Scientific literature

GHDx Entry last modified on: Oct 23, 2024

Main menu

COVID-19

Dataset Records for COVID-19

Pages